Literature DB >> 16106492

The complex antigenicity of a small external region of the C-terminal tail of the HIV-1 gp41 envelope protein: a lesson in epitope analysis.

Nigel J Dimmock1.   

Abstract

The newly discovered external tail loop within the C-terminal tail of the gp41 transmembrane subunit of the HIV-1 envelope protein comprises approximately 40 residues, and within this are 18-residues ((734)PDRPEGIEEEGGERDRDR(751)) that include three antibody-reactive regions. The antigenicity is complex, and changes according to the biological context of the gp41. It is thus of interest both to the HIV specialist and protein immunologists. The antibody-reactive region, centred on the sequence ERDRD, encompasses three distinct epitopes which are expressed in different combinations on infected cells, wt virions, prefusion virion-cell complexes, and a neutralising antibody escape mutant virion. In addition ERDRD-specific antibodies have one or more antiviral activities, and variously neutralise the infectivity of free virions, neutralise virions already attached to the target cell, reduce the production of infectious progeny, and inhibit the ability of infected cells to fuse with non-infected cells. Antibodies to PDRPEG and IEEE have no apparent antiviral activity even though the footprints of the IEEE- and ERDRD-specific antibodies overlap. This review marshals the available experimental data with the aim of understanding the significance of the gp41 tail loop to the HIV-1 life cycle, and its relevance to potential anti-viral measures. There are lessons here, too, that are relevant to the comprehension of the antigenicity of short protein segments in general.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16106492     DOI: 10.1002/rmv.476

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  10 in total

1.  Evidence against extracellular exposure of a highly immunogenic region in the C-terminal domain of the simian immunodeficiency virus gp41 transmembrane protein.

Authors:  Thomas S Postler; José M Martinez-Navio; Eloísa Yuste; Ronald C Desrosiers
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design.

Authors:  Marinieve Montero; Nienke E van Houten; Xin Wang; Jamie K Scott
Journal:  Microbiol Mol Biol Rev       Date:  2008-03       Impact factor: 11.056

3.  A low-molecular-weight entry inhibitor of both CCR5- and CXCR4-tropic strains of human immunodeficiency virus type 1 targets a novel site on gp41.

Authors:  Edward J Murray; Daniel P Leaman; Nishant Pawa; Hannah Perkins; Chris Pickford; Manos Perros; Michael B Zwick; Scott L Butler
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

Review 4.  Targeting HIV-1 gp41-induced fusion and pathogenesis for anti-viral therapy.

Authors:  Himanshu Garg; Mathias Viard; Amy Jacobs; Robert Blumenthal
Journal:  Curr Top Med Chem       Date:  2011-12       Impact factor: 3.295

5.  The membrane-spanning domain of gp41 plays a critical role in intracellular trafficking of the HIV envelope protein.

Authors:  Kosuke Miyauchi; A Rachael Curran; Yufei Long; Naoyuki Kondo; Aikichi Iwamoto; Donald M Engelman; Zene Matsuda
Journal:  Retrovirology       Date:  2010-11-13       Impact factor: 4.602

Review 6.  The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.

Authors:  Thomas S Postler; Ronald C Desrosiers
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

7.  Selected amino acid mutations in HIV-1 B subtype gp41 are associated with specific gp120v₃ signatures in the regulation of co-receptor usage.

Authors:  Salvatore Dimonte; Fabio Mercurio; Valentina Svicher; Roberta D'Arrigo; Carlo-Federico Perno; Francesca Ceccherini-Silberstein
Journal:  Retrovirology       Date:  2011-05-12       Impact factor: 4.602

8.  A New Neutralization Epitope in the Spike Protein of Porcine Epidemic Diarrhea Virus.

Authors:  Jianbo Liu; Hongyan Shi; Jianfei Chen; Xin Zhang; Da Shi; Zhaoyang Ji; Zhaoyang Jing; Li Feng
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

Review 9.  C-terminal tail of human immunodeficiency virus gp41: functionally rich and structurally enigmatic.

Authors:  Jonathan D Steckbeck; Anne-Sophie Kuhlmann; Ronald C Montelaro
Journal:  J Gen Virol       Date:  2012-10-17       Impact factor: 3.891

10.  Development and immunological assessment of VLP-based immunogens exposing the membrane-proximal region of the HIV-1 gp41 protein.

Authors:  Thomas D Benen; Paul Tonks; Alexander Kliche; Ruth Kapzan; Jonathan L Heeney; Ralf Wagner
Journal:  J Biomed Sci       Date:  2014-08-27       Impact factor: 8.410

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.